Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy [Phase 1]
Phase 1 trial evaluating magrolimab (Hu5F9-G4) with avelumab in solid tumors and checkpoint-inhibitor-naive ovarian cancer patients who prog…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) [Phase 3]
Phase 3 clinical trial evaluating tumor treating fields with weekly paclitaxel for recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4
A completed multicenter prospective study evaluated the use of ROMA and RMI algorithms along with CA125 and HE4 to differentiate benign from…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for intravenous T3011 as a single agent and in combination therapy in advanced solid tumors including hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update reporting results for pamiparib (BGB-290) in adults with advanced solid tumors, including advanced high-grad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating palbociclib plus letrozole as a second-line treatment after progression on chemotherapy in ER/PR-positive ovarian…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer [Phase 3]
Phase 3 trial of exemestane in hormone receptor–positive high-grade ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer [Phase 3]
Phase 3 trial evaluating intravenously administered iron infusion for prevention and treatment of anemia in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating dalpiciclib in combination with letrozole for recurrent ovarian carcinoma in HR+/HER2-negative gynecolog…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating lenvatinib plus toripalimab for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib with or without cediranib or chemotherapy in platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer [Phase 2, Phase 3]
Clinical trial update for SHR-A1921 with or without carboplatin in ovarian cancer is in Phase 2/Phase 3 and not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor [Phase 2]
Phase 2 clinical trial evaluating a genetic profile–guided treatment strategy for ovarian cancer patients who previously received a PARP inh…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating olaparib given before surgery and chemotherapy in ovarian, primary peritoneal, and fallopian tube cancers; current …
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) [Phase 1, Phase 2]
Phase 1/2 trial SEASTAR evaluating rucaparib in combination with other anticancer agents in solid tumors; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia [Phase 1]
Phase 1 study comparing repeated doses of an investigational drug versus placebo to assess effects on appetite in advanced cancer and anorex…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer [Phase 3]
Phase 3 trial update for intra-peritoneal local anaesthetics in advanced ovarian cancer; study status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial PROCLAIM-CX-2009 evaluating safe and active doses of CX-2009 for selected solid tumors; trial status terminated with results…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer [Phase 4]
Phase 4 trial comparing PEG-rhG-CSF as secondary prophylaxis versus therapeutic administration in ovarian cancer patients undergoing adjuvan…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 3]
Phase 3 clinical trial update evaluating maintenance therapy after platinum-containing chemotherapy in recurrent ovarian cancer; status not …
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting [Phase 2]
Phase 2 clinical trial update evaluating niraparib as maintenance therapy in patients with advanced ovarian cancer in the neoadjuvant settin…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pazopanib hydrochloride with paclitaxel and carboplatin in patients with refractory or resistant ovari…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi [Phase 2]
Phase 2 trial evaluating fluzoparib with or without apatinib in platinum-sensitive relapsed ovarian cancer previously treated with PARP inhi…